A growing number of athletes are using and endorsing CBD products

Publications were made to highlight the importance of the child's figure in the fight for treatment with Cannabis

Check out the Sechat glossary

Anvisa warns of risk of pancreatitis and reinforces that slimming pens require prescription and medical monitoring.

In an interview with the CB.Poder program of Correio Brasiliense, conducted by journalists Adriana Bernardes and Sibele Negromonte, Leandro Safatle, acting CEO of Anvisa, detailed the behind-the-scenes and expectations regarding the new regulation of medicinal cannabis and research in Brazil

2025 data shows expansion of sales in pharmacies and clubs, with an increase in the number of registered consumers and strengthened oversight in the country

Research with over 35,000 students shows that the relationship between cannabis and anxiety or depression intensified between 2013 and 2023, especially among girls and frequent users

Resolution No. 1,015/2026 tightens technical requirements, expands sanitary controls, and consolidates authorization as a transitional step before the registration of medicines

New RDC No. 1,011 expands regulatory details on Cannabis derivatives, medicinal products, and pharmaceutical inputs

Regulatory advances and scientific potential put the country on the radar of international investors and consolidate the veterinary sector

Pharmaceutical entities challenge in the Supreme Court the exclusivity of hospitals in dispensing magistral formulas based on medicinal cannabis, as provided in a recent decree

Revision of RDC 327 allows the compounding sector to produce derivatives, while individual importation by individuals remains under old rules and will be analyzed separately

Proposal aims to regulate the performance of non-profit entities in a controlled experimental environment, using the Regulatory Sandbox model to comply with STJ decision

Norm review may limit imports via RDC 660 if there is a national equivalent; director Thiago Campos presents dissenting vote

Lecture led by specialist will address scientific updates, clinical use, and regulation of cannabinoid therapies in Dentistry during the event in São Paulo

Patient follow-up for up to two years

The National Narcotics Fund (FNE) will no longer require Export Certificates for shipments destined to patients (Individuals) in Brazil, eliminating a bureaucratic obstacle that hindered the flow of derivatives between the two countries

Resumption of review by Anvisa and final deadline from STJ for cultivation define the sector's direction in the first quarter of the year

The Spanish Supreme Court has accepted the request from pharmaceutical entities challenging the exclusivity of dispensing cannabis products only in hospitals, as determined by the recent Royal Decree

CFO supports dentists among authorized professionals to prescribe safely and with quality